Viracta Therapeutics Inc (NASDAQ: VIRX) – Suitable For Long Term Buy?
Currently, there are 39.74M common shares owned by the public and among those 28.01M shares have been available to trade. The company’s stock has a 5-day price change of -52.85% and -62.05% over the past three months. VIRX shares are trading -51.65% year to date (YTD), with the 12-month market performance down to -86.35% lower. […]
Viracta Therapeutics Inc (NASDAQ: VIRX): Do Not Miss The Gain Train
Viracta Therapeutics Inc (VIRX) concluded trading on Wednesday at a closing price of $0.19, with 4.09 million shares of worth about $0.78 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.31% during that period and on January 08, 2025 the price saw a […]
